Building the Ideal Bioprocessing Strategy
Searching for Innovative, Cost-Effective Product Options
Non-Viral, Plasmid-Free CAR T-Manufacturing Platform Begins Preclinicals
Goal Is the Development of Faster, More Affordable Therapies
Top 10 European Biopharma Clusters
As Brexit Casts Uncertain Shadow, Continent’s Industry Continues Growth Trajectory
Precision CRISPR Tools Make the Cut
Genome-Editing Tools Modify More than Genomes
For full access to this article login to GEN Select now.
Stem Cells Grapple with High Expectations
Hopes Are High, Yet Potential Pitfalls Abound as Research Wends Its Way through the Clinic
- The future may not exactly rest in the figurative hands of stem cells, but David Magnus, Ph.D., director at Stanford Center of Biomedical Ethics and professor of medicine and biomedical ethics, pediatrics at Stanford University, acknowledges that the stakes are high. “There are tremendous expectations of stem cell research ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.